Business Description
Mural Oncology PLC
ISIN : IE000LK2BOB4
Share Class Description:
MURA: When IssueDescription
Mural Oncology PLC is a clinical-stage oncology company whose entire business is focused on discovering and developing immunotherapies that may meaningfully improve the lives of patients with cancer. By leveraging its core competencies in immune cell modulation and protein engineering, It has developed a portfolio of novel, investigational cytokine therapies designed to address areas of unmet need for patients with a variety of cancers. Its product candidate, Nemvaleukin is an investigational, engineered interleukin-2 cytokine designed to capture and expand the therapeutic benefits of high-dose recombinant human IL-2 while mitigating its hallmark toxicities.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 17.18 | |||||
| Equity-to-Asset | 0.89 | |||||
| Debt-to-Equity | 0.06 | |||||
| Debt-to-EBITDA | -0.07 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | N/A/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 20.36 | |||||
| 9-Day RSI | 31.68 | |||||
| 14-Day RSI | 35.89 | |||||
| 6-1 Month Momentum % | 2.27 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 11.27 | |||||
| Quick Ratio | 11.27 | |||||
| Cash Ratio | 10.9 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | 6.63 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -99.97 | |||||
| ROA % | -86.58 | |||||
| ROIC % | -597.06 | |||||
| ROC (Joel Greenblatt) % | -774.55 | |||||
| ROCE % | -92.52 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 0.26 | |||||
| Price-to-Tangible-Book | 0.26 | |||||
| EV-to-EBIT | 0.84 | |||||
| EV-to-EBITDA | 0.85 | |||||
| EV-to-FCF | 0.88 | |||||
| Price-to-Net-Current-Asset-Value | 0.29 | |||||
| Price-to-Net-Cash | 0.3 | |||||
| Earnings Yield (Greenblatt) % | 119.05 | |||||
| FCF Yield % | -294.55 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:MURA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Mural Oncology PLC Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -11.615 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 35.89 | ||
| 14-Day ATR ($) | 0.218877 | ||
| 20-Day SMA ($) | 3.7785 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range ($) | 3.23 - 17 | ||
| Shares Outstanding (Mil) | 16.92 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Mural Oncology PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Mural Oncology PLC Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Mural Oncology PLC Frequently Asked Questions
What is Mural Oncology PLC(MURA)'s stock price today?
The current price of MURA is $3.59. The 52 week high of MURA is $17.00 and 52 week low is $3.23.
When is next earnings date of Mural Oncology PLC(MURA)?
The next earnings date of Mural Oncology PLC(MURA) is 2024-08-30 Est..
Does Mural Oncology PLC(MURA) pay dividends? If so, how much?
Mural Oncology PLC(MURA) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers